Ticker
GBIOCompany Name
GENERATION BIO COSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 179.43M | $ 85.32M | 47.55% |
3/31/2025 | $ 201.35M | $ 87.58M | 43.5% |
12/31/2024 | $ 231.2M | $ 93.56M | 40.47% |
9/30/2024 | $ 248.78M | $ 93.78M | 37.69% |
6/30/2024 | $ 265.26M | $ 93.96M | 35.42% |
3/31/2024 | $ 285.88M | $ 95.94M | 33.56% |
12/31/2023 | $ 374.76M | $ 97.89M | 26.12% |
9/30/2023 | $ 381.49M | $ 79.71M | 20.9% |
6/30/2023 | $ 404.88M | $ 80.63M | 19.91% |
3/31/2023 | $ 431.42M | $ 82.36M | 19.09% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for GENERATION BIO CO is calculated as follows: Debt [ $ 0 ] / Assets [ $ 310.92M ]
(=) Debt to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |